Paid HIV Clinical Trials
HIV clinical trials now enrolling. Access long-acting treatments and cure research. Compensation up to $5,000. Studies for prevention and treatment.
Compensation
$2,500 - $5,000
Duration
48-96 weeks
Phase
Phase II/III
FDA Regulated
IRB Approved
GCP Certified
Who May Qualify
- Age 18-65 years
- Documented HIV-1 infection (for treatment studies)
- HIV-negative (for prevention studies - PrEP)
- Viral suppression on current regimen (for switch studies)
- No history of virologic failure (for some studies)
- Adequate organ function
Who May Not Qualify
- Active opportunistic infection
- Known resistance to study drug class
- Hepatitis B infection requiring treatment (for some studies)
- Current malignancy (except certain skin cancers)
- Pregnancy or breastfeeding
Frequently Asked Questions
What HIV treatments are being studied?
+
Studies include long-acting injectable regimens (monthly or less frequent), novel drug classes like capsid inhibitors, broadly neutralizing antibodies, and potentially curative strategies.
Are there studies for HIV prevention?
+
Yes, PrEP studies are testing long-acting injectable prevention options and new oral formulations for HIV-negative individuals at risk of infection.
Can I switch from my current HIV medications?
+
Switch studies enroll people who are virally suppressed on their current regimen. These studies evaluate whether new treatments maintain viral suppression with potential benefits like fewer pills or injections.
What about HIV cure research?
+
Cure-focused studies are available for participants willing to undergo treatment interruption under careful monitoring. These studies typically require sustained viral suppression and excellent health status.